Could extinct species ever be resurrected? A bioscience company insists they can, announcing on Monday its intention to use the emerging technology to bring mammoths back to the arctic tundra.
The new company Colossal, utilizing a partnership with a Harvard geneticist, said that the effort to "restore" the species, has the potential to stabilize a working model for the restoration of damaged or lost ecosystems and therefore, to slow down or even stop the effects. of climate change.
"Never before has humanity been able to harness the power of this technology to rebuild ecosystems, heal our Earth, and preserve its future through the repopulation of extinct animals."He said Ben Colm, CEO and emerging technology entrepreneur.
"In addition to bringing back ancient extinct species such as the mammoth, we will be able to use our technologies to help preserve endangered species and restore animals where humanity was responsible for their destruction. ."
Mammoths roamed much of the Arctic and coexisted with the first humans to hunt these cold-resistant herbivores for food and use their tusks and bones as tools.
Mammoths became extinct about 4.000 years ago. For decades, bioscientists have recovered pieces of tusks, bones, teeth and hair to extract and try to determine mammoth DNA.
Colossal says it aims to introduce mammoth DNA sequences, collected from well-preserved remnants of frost and icy steppes, into the Asian elephant genome to create a "elephant-mammoth hybrid».
Asian elephants and mammoths have 99,6% similar DNA synthesis, Colossal said on its website.
The co-founder of the company George Church is a renowned geneticist and professor of genetics at Harvard Medical School who uses innovative techniques, including technology CRISPR, to promote the extinction of species.
"The technologies discovered to pursue this great vision could create very important opportunities for the conservation of species and beyond.", Said Church.
Colossal says restoring mammoths has the potential to revitalize Arctic grasslands, a vast area with important anti-climate change properties, such as carbon sequestration and methane suppression.
Colossal is partly funded by $ 15 million in investors and says its advisors include leaders in bioethics and genomics.